1-17028599-C-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_003000.3(SDHB):c.423+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_003000.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SDHB | NM_003000.3 | MANE Select | c.423+1G>T | splice_donor intron | N/A | NP_002991.2 | |||
| SDHB | NM_001407361.1 | c.369+55G>T | intron | N/A | NP_001394290.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SDHB | ENST00000375499.8 | TSL:1 MANE Select | c.423+1G>T | splice_donor intron | N/A | ENSP00000364649.3 | |||
| SDHB | ENST00000714034.1 | c.468+1G>T | splice_donor intron | N/A | ENSP00000519325.1 | ||||
| SDHB | ENST00000491274.6 | TSL:5 | c.381+1G>T | splice_donor intron | N/A | ENSP00000480482.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pheochromocytoma Pathogenic:1
Pheochromocytoma/paraganglioma syndrome 4 Pathogenic:1
The variant is not observed in the gnomAD v4.1.0 dataset. Predicted Consequence/Location: Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. In silico tools predict the variant to alter splicing and produce an abnormal transcript [SpliceAI: 0.97 (spliceogenicity >=0.2, non-spliceogenicity <0.1)]. The variant has been reported to be associated with SDHB-related disorder (ClinVar ID: VCV001326294 /PMID: 36936415). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Pheochromocytoma/paraganglioma syndrome 4 Pathogenic:1
This sequence change affects a donor splice site in intron 4 of the SDHB gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in the loss of 18 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with paraganglioma (PGL) and/or pheochromocytoma (PCC) (PMID: 16405730, 19411806, 19825962, 20540712, 21348866, 25047027). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1326294). Studies have shown that disruption of this splice site results in the activation of a cryptic splice site in exon 4 (PMID: 16405730, 19411806). This variant disrupts a region of the SDHB protein in which other variant(s) (p.Val140Phe) have been determined to be pathogenic (PMID: 16912137, 19189136, 19802898). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at